leisure time -WSS

leisure time

author：explore 2025-09-06 07:21:23 Page View：6798

AbbVie announced Tuesday that CEO Richard Gonzalez, who has managed the company’s ascent since it was spun off from the device maker Abbott Laboratories in 2013, will step down in July. Gonzalez had previously said he would depart when AbbVie had a plan in place to move on from its best-selling drug, Humira, which is now facing competition from cheaper biosimilars.

He will be replaced by Chief Operating Officer Robert Michael, who, like Gonzalez, is a longtime AbbVie executive. Gonzalez, 70, will become executive chairman of the board of directors.

Gonzalez should be a sobering reminder to the drug industry’s critics of how resilient a CEO’s reputation can be. Because while he has been a subject of nearly constant criticism for AbbVie’s handling of Humira and the patents protecting it, investors are likely to remember him fondly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida
Next article： Hepatitis C has a cure — but many Americans still lack access to it

knowledge

Medical records are filled with copy

AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

1:03JackSmith,thentheDepartmentofJustice'schiefofthePublicIntegritySection,posesforphotoattheDepartm

The cancer drug shortage isn’t new — and neither are the solutions

PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

How I helped Pfizer think through the ethics of Viagra

AdobeTwenty-fiveyearsago,75-year-oldBobDole—formerRepublicanpresidentialcandidateandU.S.senatorfromK

leisure time

comprehensive

knowledge

How I helped Pfizer think through the ethics of Viagra